• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

β-Nicotinamide Mononucleotide Monoclonal antibody

β-Nicotinamide Mononucleotide Monoclonal Antibody for ELISA

Host / Isotype

Mouse / IgG1

Reactivity

Human

Applications

ELISA

Conjugate

Unconjugated

CloneNo.

3A1F11

Cat no : 68638-1-Ig

Synonyms

NMN, β NMN, β-Nicotinamide Mononucleotide, β-NMN

Validation Data Gallery

Applications:
  • ELISA experiment of β-Nicotinamide Mononucleotide using 68638-1-Ig

    ELISA experiment of β-Nicotinamide Mononucleotide using 68638-1-Ig

    Indirect ELISA and competitive ELISA results show that this antibody is specific to β-Nicotinamide Mononucleotide (NMN). Indirect ELISA was performed by coating BSA conjugated β-Nicotinamide Mononucleotide (NMN) at ~10ng/well followed by blocking with 1% BSA. Serial diluted primary antibody was added to the plates and incubated at 37℃. HRP-goat anti-mouse was used for detection. Competitive ELISA was performed similarly except that different concentration of β-Nicotinamide Mononucleotide (NMN) were mixed in primary antibody (fixed at 10 ng/mL).

  • ELISA experiment of urine using 68638-1-Ig

    ELISA experiment of urine using 68638-1-Ig

    BSA conjugated β-Nicotinamide Mononucleotide (NMN) was coated in 96 well plate at ~10 ng/well (by NMN amount), followed by blocking with 1% BSA. Different concentrations of NMN standard as well as diluted urine from NMN orally administrated mouse were mixed with 10 ng/mL β-Nicotinamide Mononucleotide antibody 68638-1-Ig respectively. Urine NMN was calculated based on standard curve.

Tested Applications

Positive ELISA detected inβ-Nicotinamide Mononucleotide, urine

Recommended dilution

ApplicationDilution
Enzyme-linked Immunosorbent Assay (ELISA)ELISA : 1:2000-1:20000
Sample-dependent, check data in validation data gallery

Product Information

68638-1-Ig targets β-Nicotinamide Mononucleotide in ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen PTG 相同性解析による交差性が予測される生物種
Full Name β-Nicotinamide Mononucleotide
Gene symbol
Gene ID (NCBI)
Conjugate Unconjugated
Form Liquid
Purification Method Protein G purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

Nicotinamide mononucleotide ("NMN" and "β-NMN") is a nucleotide derived from ribose, nicotinamide, nicotinamide riboside and niacin. In humans, several enzymes use NMN to generate nicotinamide adenine dinucleotide (NADH). In mice, it has been proposed that NMN is absorbed via the small intestine within 10 minutes of oral uptake and converted to nicotinamide adenine dinucleotide (NAD+) through the Slc12a8 transporter. However, this observation has been challenged, and the matter remains unsettled. Maintain cell quality and reduce cell aging with β-nicotinamide mononucleotide (β-NMN), an intermediate in the biosynthesis of nicotinamide adenine dinucleotide (NAD+) (Bogan & Brenner). β-NMN is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and is converted to NAD+ by nicotinamide-nucleotide adenylyltransferase.